Truncated Form of the Epstein-Barr Virus Protein EBNA-LP Protects against Caspase-Dependent Apoptosis by Inhibiting Protein Phosphatase 2A
- 15 July 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (14) , 7598-7607
- https://doi.org/10.1128/jvi.02435-06
Abstract
The Epstein-Barr virus (EBV)-encoded leader protein, EBNA-LP, strongly activates the EBNA2-mediated transcriptional activation of cellular and viral genes and is therefore important for EBV-induced B-cell transformation. However, a truncated form of EBNA-LP is produced in cells infected with variant EBV strains lacking EBNA2 due to a genetic deletion. The function of this truncated form is unknown. We show here that some Burkitt9s lymphoma cells harboring defective EBV strains are specifically resistant to the caspase-dependent apoptosis induced by verotoxin 1 (VT-1) or staurosporine. These cells produced low-molecular-weight Y1Y2-truncated isoforms of EBNA-LP, which were partly localized in the cytoplasm. The transfection of sensitive cells with constructs encoding truncated EBNA-LP isoforms, but not full-length EBNA-LP, induced resistance to caspase-mediated apoptosis. Furthermore, VT-1 induced protein phosphatase 2A (PP2A) activation in sensitive cells but not in resistant cells, in which the truncated EBNA-LP interacted with this protein. Thus, the resistance to apoptosis observed in cells harboring defective EBV strains most probably results from the inactivation of PP2A via interactions with low-molecular-weight Y1Y2-truncated EBNA-LP isoforms.Keywords
This publication has 69 references indexed in Scilit:
- Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cellsProceedings of the National Academy of Sciences, 2006
- Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) Gene Deletion Is Consistently Linked with EBNA3A, -3B, and -3C Expression in Burkitt's Lymphoma Cells and with Increased Resistance to ApoptosisJournal of Virology, 2005
- The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent PromoterJournal of Virology, 2005
- EBNA2 Is Required for Protection of Latently Epstein-Barr Virus-Infected B Cells against Specific Apoptotic StimuliJournal of Virology, 2004
- Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a proteinExperimental Cell Research, 2004
- Type-2A protein phosphatase activity is required to maintain death receptor responsivenessOncogene, 2003
- B cells under influence: transformation of B cells by Epstein–Barr virusNature Reviews Immunology, 2003
- Epstein-barr virus latent membrane protein 1: Structure and functionsJournal of Biomedical Science, 2003
- EBNA-LP Associates with Cellular Proteins Including DNA-PK and HA95Journal of Virology, 2001
- Epstein-barr virus immortalization and latencyFrontiers in Bioscience-Landmark, 1999